Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Raj Shah

Concepts (349)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Cholangiopancreatography, Endoscopic Retrograde
47
2026
223
10.110
 Why?
Endoscopy, Digestive System
24
2026
142
7.100
 Why?
Pancreatic Ducts
23
2025
82
6.820
 Why?
Pancreatic Diseases
14
2024
66
4.680
 Why?
Pancreatitis, Chronic
12
2024
65
4.370
 Why?
Calculi
8
2022
16
3.820
 Why?
Bile Duct Neoplasms
13
2021
133
3.290
 Why?
Endosonography
25
2024
162
3.270
 Why?
Lithotripsy
11
2024
49
3.140
 Why?
Stents
21
2025
570
3.130
 Why?
Cholangitis, Sclerosing
8
2022
61
2.750
 Why?
Pancreatic Neoplasms
20
2024
947
2.470
 Why?
Cholangiocarcinoma
7
2021
110
2.360
 Why?
Bile Ducts
10
2025
68
1.990
 Why?
Drainage
10
2024
189
1.940
 Why?
Bile Ducts, Intrahepatic
5
2021
63
1.870
 Why?
Cholestasis
8
2025
217
1.810
 Why?
Constriction, Pathologic
16
2025
252
1.800
 Why?
Biliary Tract Surgical Procedures
4
2021
28
1.720
 Why?
Endoscopy, Gastrointestinal
12
2023
237
1.680
 Why?
Gallstones
5
2026
35
1.470
 Why?
Laser Therapy
2
2025
146
1.260
 Why?
Pancreatic Pseudocyst
5
2024
18
1.240
 Why?
Microscopy, Confocal
8
2021
322
1.200
 Why?
Pancreas
6
2021
345
1.170
 Why?
Biliary Tract Diseases
4
2016
33
1.160
 Why?
Endoscopes
3
2017
17
1.030
 Why?
Aged
53
2026
26514
1.000
 Why?
Middle Aged
61
2026
36821
0.980
 Why?
Treatment Outcome
31
2025
11947
0.960
 Why?
Carcinoma, Pancreatic Ductal
5
2016
299
0.940
 Why?
Retrospective Studies
31
2025
17560
0.870
 Why?
Adenocarcinoma
7
2023
928
0.840
 Why?
Pancreatitis
5
2024
147
0.830
 Why?
Endoscopy
4
2015
322
0.820
 Why?
Endoscopic Ultrasound-Guided Fine Needle Aspiration
7
2019
62
0.820
 Why?
Endoscopes, Gastrointestinal
8
2013
13
0.820
 Why?
Humans
110
2026
147293
0.800
 Why?
Common Bile Duct Neoplasms
1
2023
28
0.790
 Why?
Duodenal Neoplasms
1
2023
26
0.780
 Why?
Ampulla of Vater
1
2023
40
0.780
 Why?
Choledochal Cyst
2
2020
17
0.770
 Why?
Laparoscopy
4
2021
486
0.760
 Why?
Male
66
2026
73950
0.740
 Why?
Hepatic Encephalopathy
1
2022
25
0.730
 Why?
Adenocarcinoma, Mucinous
2
2016
77
0.730
 Why?
Female
68
2026
80076
0.730
 Why?
Gastrointestinal Tract
1
2025
204
0.720
 Why?
Catheterization
8
2024
184
0.720
 Why?
Adenoma
2
2023
219
0.710
 Why?
Portasystemic Shunt, Transjugular Intrahepatic
1
2022
38
0.710
 Why?
Hypertension, Portal
1
2022
67
0.700
 Why?
Pancreatectomy
3
2021
290
0.700
 Why?
Cholangitis
1
2022
22
0.700
 Why?
End Stage Liver Disease
1
2022
95
0.660
 Why?
Calcinosis
2
2019
234
0.630
 Why?
Cytodiagnosis
1
2020
31
0.630
 Why?
Intestine, Small
2
2019
168
0.590
 Why?
In Situ Hybridization, Fluorescence
1
2020
330
0.580
 Why?
Lithotripsy, Laser
2
2015
4
0.550
 Why?
Adult
37
2026
41405
0.550
 Why?
Aged, 80 and over
18
2025
8430
0.520
 Why?
Aneurysm, False
1
2018
46
0.520
 Why?
Quality of Life
4
2024
3246
0.520
 Why?
Foreign Bodies
1
2018
110
0.500
 Why?
Disposable Equipment
1
2017
24
0.500
 Why?
Prospective Studies
23
2024
8164
0.500
 Why?
Liver Neoplasms
1
2023
787
0.500
 Why?
Artificial Intelligence
1
2022
389
0.500
 Why?
Polyethylene
1
2016
15
0.470
 Why?
Biopsy
6
2018
1093
0.460
 Why?
Follow-Up Studies
13
2025
5476
0.460
 Why?
Gallbladder Diseases
1
2015
11
0.450
 Why?
Gastroenterology
4
2019
191
0.440
 Why?
Pancreatic Juice
1
2014
3
0.430
 Why?
Gastrointestinal Diseases
5
2022
222
0.430
 Why?
Learning Curve
5
2019
71
0.420
 Why?
Sphincterotomy, Endoscopic
4
2019
29
0.410
 Why?
Biomarkers, Tumor
2
2014
1339
0.410
 Why?
Metals
4
2023
138
0.410
 Why?
CA-19-9 Antigen
1
2014
36
0.410
 Why?
Sensitivity and Specificity
9
2021
2017
0.400
 Why?
Postoperative Complications
3
2022
3022
0.380
 Why?
Cholestasis, Intrahepatic
1
2013
29
0.380
 Why?
Hemorrhage
1
2018
832
0.360
 Why?
Ultrasonography, Interventional
3
2022
166
0.360
 Why?
Pancreatitis, Acute Necrotizing
2
2023
14
0.360
 Why?
Predictive Value of Tests
7
2017
2133
0.350
 Why?
Anastomosis, Roux-en-Y
2
2022
26
0.340
 Why?
Liver Diseases
1
2014
307
0.330
 Why?
Biliary Tract Neoplasms
3
2016
31
0.320
 Why?
Young Adult
9
2025
14437
0.310
 Why?
Clinical Competence
5
2019
1260
0.310
 Why?
Foreign-Body Migration
2
2006
33
0.280
 Why?
Natural Orifice Endoscopic Surgery
3
2018
35
0.270
 Why?
Pancreatic Cyst
3
2018
50
0.270
 Why?
Needles
3
2019
63
0.270
 Why?
B7-1 Antigen
1
2008
55
0.270
 Why?
Gastrointestinal Hemorrhage
2
2008
139
0.260
 Why?
Video Recording
4
2016
222
0.260
 Why?
Fluorouracil
4
2020
232
0.250
 Why?
Bile Ducts, Extrahepatic
2
2020
20
0.250
 Why?
Gallbladder
2
2022
15
0.250
 Why?
Dilatation
2
2018
73
0.250
 Why?
Abdominal Pain
4
2023
149
0.240
 Why?
Cholelithiasis
3
2015
36
0.230
 Why?
Adolescent
11
2025
22825
0.230
 Why?
Autonomic Nerve Block
1
2024
10
0.220
 Why?
Celiac Plexus
1
2024
7
0.220
 Why?
Hemostatic Techniques
1
2005
52
0.210
 Why?
Indomethacin
1
2024
77
0.210
 Why?
Catheters
2
2015
74
0.210
 Why?
Peritoneal Neoplasms
1
2005
104
0.210
 Why?
Guanidines
1
2023
39
0.200
 Why?
Tumor Suppressor Protein p53
1
2008
536
0.200
 Why?
Ambulatory Care Facilities
1
2006
269
0.200
 Why?
Equipment Design
9
2013
527
0.200
 Why?
Esters
1
2023
71
0.190
 Why?
Prosthesis Implantation
2
2019
156
0.180
 Why?
Cholecystitis, Acute
1
2022
26
0.180
 Why?
Self Expandable Metallic Stents
1
2022
17
0.180
 Why?
Choledochostomy
1
2022
10
0.180
 Why?
Pain
3
2022
794
0.180
 Why?
Pain Measurement
1
2024
569
0.180
 Why?
Plastics
2
2022
50
0.180
 Why?
Analgesics, Opioid
2
2024
1167
0.170
 Why?
Multiple Myeloma
1
2005
310
0.170
 Why?
Multivariate Analysis
3
2021
1550
0.170
 Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2024
347
0.170
 Why?
Antimetabolites, Antineoplastic
2
2020
108
0.170
 Why?
Multicenter Studies as Topic
1
2022
417
0.160
 Why?
United States
9
2017
16313
0.160
 Why?
Lasers
1
2021
128
0.160
 Why?
Tegafur
1
2020
12
0.160
 Why?
Oxonic Acid
1
2020
13
0.160
 Why?
Fluoroscopy
4
2026
180
0.150
 Why?
Logistic Models
3
2021
2142
0.150
 Why?
Dissection
2
2018
58
0.150
 Why?
Living Donors
1
2022
289
0.150
 Why?
Fiducial Markers
1
2019
9
0.150
 Why?
Randomized Controlled Trials as Topic
4
2022
1776
0.150
 Why?
Urinary Calculi
1
2019
10
0.150
 Why?
Hydrogen Peroxide
1
2021
338
0.150
 Why?
Carcinoma, Squamous Cell
1
2004
648
0.150
 Why?
Carcinoembryonic Antigen
2
2018
40
0.140
 Why?
ROC Curve
2
2018
626
0.140
 Why?
Radiotherapy, Image-Guided
1
2019
40
0.140
 Why?
Severity of Illness Index
2
2022
2973
0.140
 Why?
Reproducibility of Results
4
2019
3448
0.140
 Why?
Anastomosis, Surgical
1
2019
167
0.140
 Why?
Lasers, Solid-State
1
2018
22
0.140
 Why?
Risk Factors
6
2024
11017
0.140
 Why?
Journal Impact Factor
1
2018
29
0.140
 Why?
Cystadenoma, Serous
1
2018
18
0.130
 Why?
Gastric Outlet Obstruction
1
2017
12
0.130
 Why?
Cholecystectomy, Laparoscopic
1
2018
56
0.130
 Why?
Fiber Optic Technology
2
2015
23
0.130
 Why?
Hospitals, University
1
2018
176
0.130
 Why?
Diagnosis, Differential
3
2015
1518
0.130
 Why?
Parkinsonian Disorders
1
2017
43
0.130
 Why?
Gastrointestinal Neoplasms
2
2008
74
0.130
 Why?
Urinary Incontinence
1
2017
65
0.130
 Why?
Narrow Band Imaging
1
2016
14
0.120
 Why?
Neoplasm Recurrence, Local
1
2023
1166
0.120
 Why?
Education, Medical, Graduate
2
2019
568
0.120
 Why?
Regression Analysis
1
2018
1003
0.120
 Why?
Feasibility Studies
4
2018
1147
0.120
 Why?
Neuroendocrine Tumors
1
2018
123
0.120
 Why?
Time Factors
3
2019
7173
0.120
 Why?
Reoperation
1
2019
644
0.120
 Why?
Gastric Bypass
1
2017
126
0.120
 Why?
Neoplasms, Cystic, Mucinous, and Serous
1
2016
27
0.110
 Why?
Neoplasm Staging
6
2013
1492
0.110
 Why?
Cystadenoma, Mucinous
1
2015
11
0.110
 Why?
Periodicals as Topic
1
2018
211
0.110
 Why?
Cystadenocarcinoma, Mucinous
1
2015
12
0.110
 Why?
Pathology, Clinical
1
2015
29
0.110
 Why?
Radio Waves
1
2015
28
0.110
 Why?
Single-Blind Method
1
2016
319
0.110
 Why?
Fellowships and Scholarships
1
2019
357
0.110
 Why?
Pancreaticoduodenectomy
1
2016
149
0.110
 Why?
Incidence
2
2018
2954
0.100
 Why?
Europe
1
2014
426
0.100
 Why?
Tertiary Care Centers
1
2014
196
0.100
 Why?
Double-Balloon Enteroscopy
1
2013
1
0.100
 Why?
Disinfection
2
2018
131
0.100
 Why?
Length of Stay
1
2019
1371
0.090
 Why?
Antineoplastic Combined Chemotherapy Protocols
2
2013
2001
0.090
 Why?
Databases, Factual
1
2018
1504
0.090
 Why?
Cyst Fluid
2
2018
20
0.090
 Why?
Colonoscopy
2
2018
266
0.090
 Why?
Carcinoma
1
2013
231
0.080
 Why?
Chemoradiotherapy
1
2013
239
0.080
 Why?
Technology Assessment, Biomedical
2
2008
45
0.080
 Why?
Deoxycytidine
2
2013
220
0.080
 Why?
Academic Medical Centers
2
2017
566
0.080
 Why?
Biopsy, Fine-Needle
2
2008
79
0.080
 Why?
Cohort Studies
2
2014
6099
0.080
 Why?
Esophageal Neoplasms
2
2005
351
0.080
 Why?
Catheter Ablation
1
2015
360
0.080
 Why?
Antibiotic Prophylaxis
1
2012
135
0.080
 Why?
Parkinson Disease
1
2017
613
0.080
 Why?
Radiography
1
2013
862
0.080
 Why?
Referral and Consultation
2
2016
886
0.080
 Why?
Child
4
2018
22979
0.080
 Why?
Practice Guidelines as Topic
1
2018
1598
0.080
 Why?
Minimally Invasive Surgical Procedures
2
2008
192
0.080
 Why?
Colorado
2
2018
4591
0.070
 Why?
Abdominal Abscess
1
2009
28
0.070
 Why?
Colonography, Computed Tomographic
1
2009
8
0.070
 Why?
Intestinal Perforation
1
2008
46
0.070
 Why?
Capsule Endoscopy
1
2008
25
0.070
 Why?
Decompression, Surgical
1
2009
117
0.070
 Why?
Risk Assessment
4
2016
3784
0.070
 Why?
Duodenum
1
2008
80
0.070
 Why?
Gastric Mucosa
1
2008
54
0.070
 Why?
Prognosis
3
2016
4383
0.070
 Why?
V-Set Domain-Containing T-Cell Activation Inhibitor 1
1
2008
6
0.070
 Why?
Tissue Fixation
1
2008
37
0.070
 Why?
NAD(P)H Dehydrogenase (Quinone)
1
2008
37
0.070
 Why?
Equipment Safety
4
2008
38
0.070
 Why?
Palliative Care
2
2009
1032
0.070
 Why?
Wounds, Penetrating
1
2008
72
0.070
 Why?
Balloon Occlusion
1
2008
39
0.070
 Why?
Immunoenzyme Techniques
1
2008
200
0.070
 Why?
Medical Records Systems, Computerized
1
2008
96
0.060
 Why?
Coloring Agents
1
2007
90
0.060
 Why?
Radiotherapy, Intensity-Modulated
1
2008
143
0.060
 Why?
Image Enhancement
1
2008
201
0.060
 Why?
Rectal Neoplasms
1
2008
159
0.060
 Why?
Duodenoscopy
1
2006
8
0.060
 Why?
Liver
2
2005
1916
0.060
 Why?
Laser Coagulation
1
2006
80
0.060
 Why?
Prosthesis Design
2
2009
363
0.060
 Why?
Intestinal Mucosa
2
2008
676
0.060
 Why?
Tomography, X-Ray Computed
2
2014
2791
0.060
 Why?
Anesthesia, General
1
2006
121
0.060
 Why?
Radiation Exposure
1
2026
63
0.060
 Why?
Ascites
1
2005
48
0.050
 Why?
Operative Time
1
2026
195
0.050
 Why?
Thoracic Neoplasms
1
2005
40
0.050
 Why?
Acute Disease
1
2008
1049
0.050
 Why?
Administration, Rectal
1
2024
14
0.050
 Why?
Equipment Failure
1
2005
115
0.050
 Why?
Growth Substances
1
2004
138
0.050
 Why?
Radiotherapy, Adjuvant
3
2013
222
0.050
 Why?
Pain Management
1
2008
415
0.050
 Why?
Immunoglobulin A
1
2005
214
0.050
 Why?
Liver Cirrhosis
1
2006
289
0.050
 Why?
Chemotherapy, Adjuvant
3
2013
429
0.050
 Why?
Infant
1
2018
10194
0.050
 Why?
International Cooperation
2
2017
198
0.050
 Why?
Neoplasm Metastasis
1
2005
695
0.050
 Why?
Diagnostic Tests, Routine
1
2003
107
0.050
 Why?
Child, Preschool
1
2018
12016
0.050
 Why?
Necrosis
1
2023
245
0.040
 Why?
Pilot Projects
1
2008
1912
0.040
 Why?
Odds Ratio
2
2016
1084
0.040
 Why?
Combined Modality Therapy
3
2013
1281
0.040
 Why?
Polycystic Kidney, Autosomal Dominant
1
2004
244
0.040
 Why?
Anti-Infective Agents, Local
1
2021
41
0.040
 Why?
Drug Combinations
1
2020
399
0.040
 Why?
Disease-Free Survival
2
2013
779
0.040
 Why?
Double-Blind Method
1
2023
2080
0.030
 Why?
Kaplan-Meier Estimate
2
2013
975
0.030
 Why?
Myotomy
1
2018
15
0.030
 Why?
Equipment Contamination
1
2018
67
0.030
 Why?
Republic of Korea
1
2017
43
0.030
 Why?
Endoscopic Mucosal Resection
1
2018
39
0.030
 Why?
Surgical Instruments
1
2018
51
0.030
 Why?
Administration, Oral
1
2020
874
0.030
 Why?
Bile
2
2009
26
0.030
 Why?
Autopsy
1
2017
96
0.030
 Why?
Surgery, Computer-Assisted
1
2018
86
0.030
 Why?
Prosthesis Failure
2
2009
127
0.030
 Why?
Colonic Polyps
1
2018
88
0.030
 Why?
Cytokines
1
2004
2086
0.030
 Why?
United Kingdom
1
2017
391
0.030
 Why?
Videotape Recording
1
2016
37
0.030
 Why?
Gastroenterologists
1
2016
21
0.030
 Why?
Hospitalization
1
2006
2496
0.030
 Why?
Quality Indicators, Health Care
1
2018
337
0.030
 Why?
Radiologists
1
2016
61
0.030
 Why?
Geriatric Assessment
1
2017
240
0.030
 Why?
Barrett Esophagus
1
2018
172
0.030
 Why?
Watchful Waiting
1
2016
90
0.030
 Why?
Surveys and Questionnaires
1
2008
6164
0.030
 Why?
Phantoms, Imaging
1
2016
159
0.030
 Why?
Disease Management
1
2018
654
0.030
 Why?
Societies, Medical
2
2008
914
0.020
 Why?
Inflammatory Bowel Diseases
1
2018
366
0.020
 Why?
Organoplatinum Compounds
1
2013
65
0.020
 Why?
Leucovorin
1
2013
98
0.020
 Why?
Injections, Intralesional
1
2013
35
0.020
 Why?
Erlotinib Hydrochloride
1
2013
72
0.020
 Why?
Program Evaluation
1
2017
952
0.020
 Why?
Camptothecin
1
2013
138
0.020
 Why?
Comorbidity
1
2017
1672
0.020
 Why?
Treatment Failure
1
2013
360
0.020
 Why?
False Negative Reactions
1
2011
61
0.020
 Why?
Quinazolines
1
2013
266
0.020
 Why?
False Positive Reactions
1
2011
124
0.020
 Why?
Drug Administration Schedule
1
2013
789
0.020
 Why?
Neoadjuvant Therapy
1
2013
474
0.020
 Why?
Colorectal Neoplasms
1
2018
876
0.020
 Why?
Longitudinal Studies
1
2017
3027
0.020
 Why?
Stainless Steel
1
2009
19
0.020
 Why?
Alloys
1
2009
37
0.020
 Why?
Hematoma
1
2009
63
0.020
 Why?
Terminally Ill
1
2009
40
0.020
 Why?
Observer Variation
1
2010
358
0.020
 Why?
Medical Laboratory Science
1
2008
9
0.020
 Why?
Rupture
1
2008
91
0.020
 Why?
Miniaturization
1
2008
22
0.020
 Why?
Ligation
1
2008
91
0.020
 Why?
Probability
1
2009
309
0.020
 Why?
Capecitabine
1
2008
56
0.020
 Why?
Premedication
1
2008
45
0.020
 Why?
Total Quality Management
1
2008
57
0.020
 Why?
Evaluation Studies as Topic
1
2008
164
0.020
 Why?
Forms and Records Control
1
2008
20
0.020
 Why?
Esophageal and Gastric Varices
1
2008
36
0.020
 Why?
Radiotherapy Dosage
1
2008
289
0.020
 Why?
Morbidity
1
2008
323
0.020
 Why?
Remission Induction
1
2008
310
0.020
 Why?
Biopsy, Needle
1
2007
186
0.020
 Why?
Diarrhea
1
2008
193
0.020
 Why?
Safety Management
1
2008
128
0.020
 Why?
Injections
1
2007
200
0.020
 Why?
Costs and Cost Analysis
1
2007
221
0.020
 Why?
DNA
1
2013
1444
0.010
 Why?
Survival Analysis
1
2009
1386
0.010
 Why?
Information Dissemination
1
2008
227
0.010
 Why?
Safety
1
2007
358
0.010
 Why?
Prostheses and Implants
1
2006
137
0.010
 Why?
Patient Selection
1
2009
746
0.010
 Why?
Receptors, Interleukin-8B
1
2004
29
0.010
 Why?
Obesity
1
2018
3149
0.010
 Why?
Esophagectomy
1
2005
136
0.010
 Why?
Recurrence
1
2007
1151
0.010
 Why?
Survival Rate
1
2008
2110
0.010
 Why?
Swine
1
2006
828
0.010
 Why?
Positron-Emission Tomography
1
2005
344
0.010
 Why?
Ischemia
1
2004
424
0.010
 Why?
Epithelial Cells
1
2004
1141
0.010
 Why?
Cells, Cultured
1
2004
4169
0.010
 Why?
Biomarkers
1
2008
4351
0.010
 Why?
Disease Models, Animal
1
2006
4604
0.010
 Why?
Animals
1
2006
38410
0.000
 Why?
Shah's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (349) concept(s)
_
Co-Authors Expand Description
See all (23) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)